Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Caroline Joyce und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Point-of-Care Systems, Point-of-Care Testing, Pregnancy Complications. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council.
Abstract (Originalsprache)
Objectives
To evaluate the use of the Abbott i‐STAT®1 point‐of‐care‐test (POCT) device for measurement of human chorionic gonadotropin (hCG) to support the management of early pregnancy complications in a remote early pregnancy unit (EPU).
Methods
Women attending the EPU who required an hCG blood test were invited to take part in the study. Participants provided an additional blood sample for whole blood hCG measurement using the Abbott i‐STAT®1 analyzer. The remaining sample was sent to the hospital laboratory for hCG analysis using the Abbott Architect, the designated comparator method. Statistical analysis was performed using Analyze‐IT software.
Results
A total of 61 women were recruited, including cases of pregnancy of unknown location, ectopic pregnancy, and molar pregnancy. Fourteen hCG results that were outside the i‐STAT®1 assay's quantitative range, although still broadly concordant with laboratory hCG results, were excluded from statistical analysis. Analysis of the remaining 47 paired hCG results demonstrated strong agreement across the concentration range (4–2072 IU/L), with excellent Spearman correlation ( r = 0.99, P < 0.001). Passing‐Bablok linear regression indicated good agreement ( y = 1.18 + 0.96 x ) and Bland–Altman analysis showed a mean difference of −23.7 IU/L (−3.5%).
Conclusions
All hCG results from the i‐STAT®1 analyzer were clinically concordant with the central laboratory method, supporting its application in an EPU setting using established clinical decision thresholds. However, further verification through larger‐scale studies is necessary before the i‐STAT®1 analyzer can be integrated into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland.
- INFANT Research Centre, University College Cork, Cork, Ireland.
- Department of Biochemistry & Cell Biology, University College Cork, Cork, Ireland.
- Department of Clinical Biochemistry, Cork University Hospital, Cork, Ireland.
- Department of Clinical Biochemistry & Diagnostic Endocrinology, The Mater Misericordiae University Hospital, Dublin, Ireland.
- Department of Obstetrics & Gynaecology, Cork University Maternity Hospital, Cork, Ireland.
ORCID-Profile: Caroline Joyce, Paula M O'Shea, Seán J Costelloe, Tommie V McCarthy, Deirdre Hayes-Ryan, Keelin O'Donoghue
Förderung
- Irish Research Council
Zitieren
APA
Joyce, C., O'Shea, P. M., Lynch, R., Costelloe, S. J., McCarthy, T. V., Coulter, J., Hayes-Ryan, D., & O'Donoghue, K. (2025). Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70217
Vancouver
Joyce C, O'Shea PM, Lynch R, Costelloe SJ, McCarthy TV, Coulter J, et al. Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70217
BibTeX
@article{Joyce2025,
author = {Joyce, Caroline and O'Shea, Paula M and Lynch, Rebecca and Costelloe, Seán J and McCarthy, Tommie V and Coulter, John and Hayes-Ryan, Deirdre and O'Donoghue, Keelin},
title = {Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70217}
}
EUVIMED